Portal's Flavin on Biotech & Pharma Deals in 2026
Summarize this article with:
Live on Bloomberg TVPortal's Flavin on Biotech & Pharma Deals in 2026Bloomberg Markets: The CloseDecember 17th, 2025, 11:09 PM GMT+0000John Flavin, founder and CEO of Portal Innovations, says billions of dollars in biotech M&A have taken place this year. He tells Romaine Bostick and Katie Greifeld on “The Close” that new offerings are helping funnel capital into fresh opportunities and innovation. (Source: Bloomberg)More From Bloomberg Markets: The Close09:37CVS Health's Chaguturu on Oak Street, Tech Investment28 minutes ago08:00Guggenheim's DiLorenzo Sees Private Credit Growing Into 202652 minutes ago03:14Micron Gives Upbeat Forecast Amid AI Boom1 hours ago10:42Stocks Slip as Oracle and Nvidia Weigh on AI Trade | Closing Bell2 hours agoAll episodes and clipsBloomberg TechnologyThe only daily news program focused exclusively on technology, innovation and the future of business from San Francisco. Hosted by Emily Chang.More episodes and clips44:04Investors Question Oracle’s Data Center Financing | Bloomberg Tech 12/17/202502:30Warner Bros. Urges Investors to Reject Paramount04:27Imprint Payments Propelled to $1.2B Valuation05:42Micron’s Persistent DRAM DemandThe David Rubenstein Show"The David Rubenstein Show: Peer-to-Peer Conversations" explores successful leadership through the personal and professional choices of the most influential people in business.More episodes and clips24:06The David Rubenstein Show: Ynon Kreiz24:05David Rubenstein Show: Kevin Hassett24:05The David Rubenstein Show: Maria Sharapova24:06The David Rubenstein Show: Justice Anthony KennedySee all shows